01 / ATLAS

What it is

GHK-Cu is the complex of the tripeptide glycyl–histidyl–lysine with a copper ion. This entry covers skin and extracellular matrix research. [1]

02 / ATLAS

How it works

Fibroblast experiments investigated changes in collagen synthesis. These cells produce components of the matrix supporting tissues. [1]

03 / ATLAS

What research shows

Laboratory findings support interest in skin repair and aging. Effects measured in cells do not automatically demonstrate a visible benefit in people. [1]

A 2023 study tested GHK-Cu with hyaluronic acid. Findings for that formulation cannot automatically be applied to GHK-Cu alone. [2]

04 / ATLAS

Study data

Maquart et al., 1988: fibroblast cultures, measuring collagen synthesis. [1]

Jiang et al., 2023: cell and ex vivo skin tests examining the GHK-Cu–hyaluronic acid combination and collagen IV. This was not a clinical efficacy trial of injections. [2]

05 / ATLAS

Safety and observed adverse reactions

The FDA notes limited human data and potential immune-response and impurity risks for injectable forms. [3]

Data on a topical formulation do not establish the safety of the same molecule given by another route.

06 / ATLAS

Research status

The selected evidence is preclinical. Cosmetic use and investigation as a treatment are different contexts; this entry does not establish an administration protocol.

07 / REFERENCES

Studies and sources

  1. Maquart et al. · Collagen synthesis in fibroblasts (1988) ↗Original research · in vitro
  2. Jiang et al. · GHK-Cu and hyaluronic acid (2023) ↗Original research · cells and ex vivo skin
  3. FDA · Safety information for injectable GHK-Cu ↗Official assessment · United States
Back to the atlasFurther information / Contact